ProKidney Corp. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ProKidney Corp. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $0.00.
- ProKidney Corp. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $7.00K.
- ProKidney Corp. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $17.14M.
- ProKidney Corp. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $7.10M, a 58.90% increase year-over-year.
- ProKidney Corp. stock issued during period, value, new issues for fiscal 2025 was $24.25M, a 83.20% decline from fiscal 2024.
- ProKidney Corp. stock issued during period, value, new issues for fiscal 2024 was $144.32M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $24.25M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $17.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $24.25M 10-K · filed 2026-03-18 |
| 2025-09-30 | $7.10M 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $144.32M 10-K · filed 2026-03-18 |
| 2024-09-30 | $4.47M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $139.85M 10-Q · filed 2025-08-12 | |
| 2021-09-30 | $6.40M 10-Q · filed 2021-11-15 |